To develop a gene signature effectively characterizing the IFNG response for GBM, DEGs significantly up- and down-regulated across 3 datasets were calculated respectively and intersected to harvest 207 co-upregulated DEGs, as well as 31 co-downregulated DEGs as candidates (Figure 1A). The gene discussed is IFNG; the disease is glioblastoma.